imiquimod has been researched along with Itching in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 10 (43.48) | 24.3611 |
| 2020's | 8 (34.78) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Ge, W; Huang, Y; Jiang, J; Jin, Z; Kong, Y; Li, F; Li, L; Li, M; Liu, X; Zeng, X; Zhanmu, O | 1 |
| Chen, K; Li, XZ; Liu, X; Tian, JY; Wang, Y; Xu, ZH; Yuan, M; Zhang, JC | 1 |
| Fukazawa, Y; Kiguchi, N; Kishioka, S; Saika, F | 1 |
| Guillaume, P; Lariosa-Willingham, K; Leonoudakis, D; Simon, F; Stratton, J; Walker, K; Warren, L | 1 |
| Fukuyama, T; Iwano, R; Iwashita, N; Takagi, Y | 1 |
| Fukazawa, Y; Kiguchi, N; Kishioka, S; Matsuzaki, S; Saika, F | 1 |
| Huang, X; Li, Q; Mei, Z; Tu, C; Wang, W; Xiang, X; Xiong, H; Zhao, Z | 1 |
| Huang, X; Mei, Z; Wang, H; Wang, W; Xiong, H; Zhao, Z | 1 |
| Akiyama, T; Jensen, LE; Sakai, K; Sanders, KM; Yanushefski, KM; Yosipovitch, G; Youssef, MR | 1 |
| Condon, L; Curtright, A; Dhaka, A; Esancy, K; Feng, J; Kimball, C | 1 |
| Akiyama, T; Hashimoto, T; Sakai, K; Sanders, KM; Yosipovitch, G | 1 |
| Akiyama, T; Sakai, K | 1 |
| Honda, K; Lee, HC; Ohba, M; Okuno, T; Takahashi, N; Takamori, K; Tominaga, M; Yasukawa, K; Yokomizo, T | 1 |
| Dainichi, T; Hirakawa, S; Honda, T; Kabashima, K; Kitoh, A; Miyachi, Y; Nakajima, S; Nakashima, C; Nonomura, Y; Otsuka, A; Wong, LS; Yamamoto, Y | 1 |
| Akiyama, T; Jensen, L; Sakai, K; Sanders, KM; Yanushefski, KM; Yosipovitch, G; Youssef, MR | 1 |
| Al Saïf, F; Carmi, E; Dillies, AS; Fraitag-Spinner, S; Gras-Champel, V | 1 |
| Berta, T; Ji, RR; Liu, T; Park, CK; Xu, ZZ | 1 |
| Han, SK; Kim, D; Kim, SJ; Lee, CJ; Lee, J; Lee, SJ; Min, H; Park, GH; Simon, MI; Wall, E | 1 |
| Bayerl, C; Feller, G; Goerdt, S | 1 |
| Colaco, SM; Heaphy, MR; Palmer, G; Ricotti, CA; Shamma, HN; Trevino, J | 1 |
| Barasso, R; Carey-Yard, M; Eul, A; Gollnick, H; Jappe, U; Milde, K; Ward, K | 1 |
| Barba, AR; Berman, B; Kapoor, S | 1 |
| Flowers, F | 1 |
3 trial(s) available for imiquimod and Itching
| Article | Year |
|---|---|
Laser-assisted tattoo removal with topical 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Combined Modality Therapy; Double-Blind Method; Erythema; Humans; Imiquimod; Laser Therapy; Prospective Studies; Pruritus; Tattooing | 2007 |
Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Erythema; France; Germany; Humans; Imiquimod; Interferon Inducers; Male; Pain; Penile Diseases; Pruritus | 2001 |
An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.
Topics: Administration, Topical; Adolescent; Aminoquinolines; Child; Child, Preschool; Erythema; Humans; Imiquimod; Infant; Interferon Inducers; Molluscum Contagiosum; Pruritus | 2001 |
20 other study(ies) available for imiquimod and Itching
| Article | Year |
|---|---|
Role of Type I Cannabinoid Receptor in Sensory Neurons in Psoriasiform Skin Inflammation and Pruritus.
Topics: Animals; Eczema; Imiquimod; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Pruritus; Psoriasis; Receptors, Cannabinoid; Sensory Receptor Cells; Substance P | 2023 |
Mechanisms of the PD-1/PD-L1 pathway in itch: From acute itch model establishment to the role in chronic itch in mouse.
Topics: Animals; B7-H1 Antigen; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Imiquimod; Immune Checkpoint Inhibitors; Mice; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Pruritus; Psoriasis; Spinal Cord Dorsal Horn | 2023 |
Characterization of spinal microglial activation in a mouse model of imiquimod-induced psoriasis.
Topics: Animals; Disease Models, Animal; Imiquimod; Mice; Microglia; Pruritus; Psoriasis; Spinal Cord | 2023 |
Imiquimod-induced pruritus in female wild-type and knockin Wistar rats: underscoring behavioral scratching in a rat model for antipruritic treatments.
Topics: Animals; Antipruritics; Disease Models, Animal; Female; Imiquimod; Mice; Mice, Inbred C57BL; Pruritus; Psoriasis; Rats; Rats, Wistar; Skin | 2023 |
Estrogen receptor α activation aggravates imiquimod-induced psoriasis-like dermatitis in mice by enhancing dendritic cell interleukin-23 secretion.
Topics: Animals; Dendritic Cells; Estrogen Receptor alpha; Humans; Imiquimod; Inflammation; Interleukin-23; Male; Mice; Models, Animal; Pruritus; Psoriasis | 2020 |
Critical role of GRP receptor-expressing neurons in the spinal transmission of imiquimod-induced psoriatic itch.
Topics: Adjuvants, Immunologic; Animals; Gene Expression; Imiquimod; Male; Mice; Mice, Inbred C57BL; Neurons; Posterior Horn Cells; Pruritus; Receptors, Bombesin | 2020 |
Oxymatrine ameliorates imiquimod-induced psoriasis pruritus and inflammation through inhibiting heat shock protein 90 and heat shock protein 60 expression in keratinocytes.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Chaperonin 60; Disease Models, Animal; Down-Regulation; HaCaT Cells; HSP90 Heat-Shock Proteins; Humans; Imiquimod; Keratinocytes; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Pruritus; Psoriasis; Quinolizines | 2020 |
Thymol activates TRPM8-mediated Ca
Topics: Animals; Antipruritics; Behavior, Animal; Calcium; Cell Differentiation; Cytokines; Imiquimod; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurons; Pruritus; Psoriasis; Skin; Thymol; TRPM Cation Channels | 2020 |
Role of neurturin in spontaneous itch and increased nonpeptidergic intraepidermal fiber density in a mouse model of psoriasis.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibodies; Calcitonin Gene-Related Peptide; Disease Models, Animal; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Glial Cell Line-Derived Neurotrophic Factor Receptors; Imiquimod; Male; Mice; Mice, Inbred C57BL; Nerve Fibers; Neurturin; Pruritus; Psoriasis; Receptors, Purinergic P2X3; RNA, Messenger; Skin | 2017 |
A zebrafish and mouse model for selective pruritus via direct activation of TRPA1.
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Evoked Potentials, Somatosensory; HEK293 Cells; Humans; Imiquimod; Isothiocyanates; Larva; Membrane Potentials; Mice; Neurons; Pruritus; TRPA1 Cation Channel; Zebrafish; Zebrafish Proteins | 2018 |
Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis.
Topics: Animals; Antipruritics; Behavior, Animal; Disease Models, Animal; Imiquimod; Interleukin-22; Interleukin-23; Interleukins; Janus Kinase Inhibitors; Male; Mice, Inbred C57BL; Nerve Fibers; Piperidines; Pruritus; Psoriasis; Pyrimidines; Pyrroles; Skin | 2019 |
Disinhibition of Touch-Evoked Itch in a Mouse Model of Psoriasis.
Topics: Animals; Disease Models, Animal; Epidermis; Humans; Imiquimod; Interneurons; Male; Merkel Cells; Mice; Neurofilament Proteins; Pruritus; Psoriasis; Touch | 2019 |
Dietary supplementation of omega-3 fatty acid eicosapentaenoic acid does not ameliorate pruritus in murine models of atopic dermatitis and psoriasis.
Topics: Animals; Antigens, Dermatophagoides; Dermatitis, Atopic; Dietary Supplements; Disease Models, Animal; Eicosanoids; Eicosapentaenoic Acid; Humans; Imiquimod; Lipid Metabolism; Male; Mice; Pruritus; Psoriasis; Skin; Treatment Outcome | 2019 |
Vascular endothelial growth factor partially induces pruritus via epidermal hyperinnervation in imiquimod-induced psoriasiform dermatitis in mice.
Topics: Aminoquinolines; Animals; Axitinib; Dermatitis, Atopic; Disease Models, Animal; Epidermis; Humans; Imidazoles; Imiquimod; Indazoles; Mice; Pruritus; Psoriasis; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2016 |
Mouse model of imiquimod-induced psoriatic itch.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipruritics; Chlorpheniramine; Disease Models, Animal; Ganglia, Spinal; Gene Expression Regulation; Histidine Decarboxylase; Imiquimod; Male; Mice; Mice, Inbred C57BL; Olopatadine Hydrochloride; Pain Measurement; Pruritus; Random Allocation; Skin; TRPV Cation Channels; Tryptophan Hydroxylase | 2016 |
[Eruptive epidermoid cysts during topical imiquimod treatment].
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diagnosis, Differential; Eyebrows; Humans; Imiquimod; Keratosis; Male; Pruritus; Skin Neoplasms | 2017 |
Toll-like receptor 7 mediates pruritus.
Topics: Aminoquinolines; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Female; Histamine; Imiquimod; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nerve Fibers, Unmyelinated; Pain Measurement; Pruritus; Toll-Like Receptor 7 | 2010 |
Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons.
Topics: Aminoquinolines; Animals; Chloroquine; Histamine; Imiquimod; Interferon Inducers; Mice; Neurons; Pruritus; TRPV Cation Channels | 2011 |
Experience in treating molluscum contagiosum in children with imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Aminoquinolines; Child; Child, Preschool; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Humans; Imiquimod; Male; Molluscum Contagiosum; Ointments; Pain; Pruritus | 2003 |
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bowen's Disease; Cicatrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Paget Disease, Extramammary; Photochemotherapy; Pruritus; Randomized Controlled Trials as Topic; Skin Neoplasms | 2002 |